BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35237602)

  • 1. Overexpression of MUC1 Induces Non-Canonical TGF-β Signaling in Pancreatic Ductal Adenocarcinoma.
    Bose M; Grover P; Sanders AJ; Zhou R; Ahmad M; Shwartz S; Lala P; Nath S; Yazdanifar M; Brouwer C; Mukherjee P
    Front Cell Dev Biol; 2022; 10():821875. PubMed ID: 35237602
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SMAD4-independent activation of TGF-β signaling by MUC1 in a human pancreatic cancer cell line.
    Grover P; Nath S; Nye MD; Zhou R; Ahmad M; Mukherjee P
    Oncotarget; 2018 Jan; 9(6):6897-6910. PubMed ID: 29467938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin1 mediates autocrine transforming growth factor beta signaling through activating the c-Jun N-terminal kinase/activator protein 1 pathway in human hepatocellular carcinoma cells.
    Li Q; Liu G; Shao D; Wang J; Yuan H; Chen T; Zhai R; Ni W; Tai G
    Int J Biochem Cell Biol; 2015 Feb; 59():116-25. PubMed ID: 25526895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
    Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
    Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MUC1 enhances tumor progression and contributes toward immunosuppression in a mouse model of spontaneous pancreatic adenocarcinoma.
    Tinder TL; Subramani DB; Basu GD; Bradley JM; Schettini J; Million A; Skaar T; Mukherjee P
    J Immunol; 2008 Sep; 181(5):3116-25. PubMed ID: 18713982
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-β/Smad signaling pathways.
    Guo Y; Tong Y; Zhu H; Xiao Y; Guo H; Shang L; Zheng W; Ma S; Liu X; Bai Y
    Cell Biol Toxicol; 2021 Jun; 37(3):479-496. PubMed ID: 33070227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor-associated MUC1 overcomes anoikis-resistance in pancreatic cancer.
    Bose M; Sanders A; De C; Zhou R; Lala P; Shwartz S; Mitra B; Brouwer C; Mukherjee P
    Transl Res; 2023 Mar; 253():41-56. PubMed ID: 36031050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pancreatic ductal adenocarcinoma mice lacking mucin 1 have a profound defect in tumor growth and metastasis.
    Besmer DM; Curry JM; Roy LD; Tinder TL; Sahraei M; Schettini J; Hwang SI; Lee YY; Gendler SJ; Mukherjee P
    Cancer Res; 2011 Jul; 71(13):4432-42. PubMed ID: 21558393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MUC1 regulates PDGFA expression during pancreatic cancer progression.
    Sahraei M; Roy LD; Curry JM; Teresa TL; Nath S; Besmer D; Kidiyoor A; Dalia R; Gendler SJ; Mukherjee P
    Oncogene; 2012 Nov; 31(47):4935-45. PubMed ID: 22266848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic vesicular stomatitis virus in an immunocompetent model of MUC1-positive or MUC1-null pancreatic ductal adenocarcinoma.
    Hastie E; Besmer DM; Shah NR; Murphy AM; Moerdyk-Schauwecker M; Molestina C; Roy LD; Curry JM; Mukherjee P; Grdzelishvili VZ
    J Virol; 2013 Sep; 87(18):10283-94. PubMed ID: 23864625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting MUC1 and JNK by RNA interference and inhibitor inhibit the development of hepatocellular carcinoma.
    Wang J; Ni WH; Hu KB; Zhai XY; Xie F; Jie J; Zhang NN; Jiang LN; Yuan HY; Tai GX
    Cancer Sci; 2017 Mar; 108(3):504-511. PubMed ID: 28012230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining the Specific Anti-MUC1 Antibody TAB004 and Lip-MSA-IL-2 Limits Pancreatic Cancer Progression in Immune Competent Murine Models of Pancreatic Ductal Adenocarcinoma.
    Dréau D; Moore LJ; Wu M; Roy LD; Dillion L; Porter T; Puri R; Momin N; Wittrup KD; Mukherjee P
    Front Oncol; 2019; 9():330. PubMed ID: 31114758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-143 Targeting TAK1 Attenuates Pancreatic Ductal Adenocarcinoma Progression via MAPK and NF-κB Pathway In Vitro.
    Huang FT; Peng JF; Cheng WJ; Zhuang YY; Wang LY; Li CQ; Tang J; Chen WY; Li YH; Zhang SN
    Dig Dis Sci; 2017 Apr; 62(4):944-957. PubMed ID: 28194669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic Cancer Cells Isolated from Muc1-Null Tumors Favor the Generation of a Mature Less Suppressive MDSC Population.
    Kidiyoor A; Schettini J; Besmer DM; Rego SL; Nath S; Curry JM; Roy LD; Dréau D; Mukherjee P
    Front Immunol; 2014; 5():67. PubMed ID: 24605110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis.
    Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P
    Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC1 Promoter-Driven DTA as a Targeted Therapeutic Strategy against Pancreatic Cancer.
    Tholey RM; Lal S; Jimbo M; Burkhart RA; Blanco FF; Cozzitorto JA; Eisenberg JD; Jiang W; Iacobuzio-Donahue CA; Witkiewicz AK; Glbert M; Yeo CJ; Brody JR; Sawicki JA; Winter JM
    Mol Cancer Res; 2015 Mar; 13(3):439-48. PubMed ID: 25336517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucin 1 Regulates Cox-2 Gene in Pancreatic Cancer.
    Nath S; Roy LD; Grover P; Rao S; Mukherjee P
    Pancreas; 2015 Aug; 44(6):909-17. PubMed ID: 26035123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia and Transforming Growth Factor β Cooperate to Induce Fibulin-5 Expression in Pancreatic Cancer.
    Topalovski M; Hagopian M; Wang M; Brekken RA
    J Biol Chem; 2016 Oct; 291(42):22244-22252. PubMed ID: 27531748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overcoming Immunological Resistance Enhances the Efficacy of A Novel Anti-tMUC1-CAR T Cell Treatment against Pancreatic Ductal Adenocarcinoma.
    Yazdanifar M; Zhou R; Grover P; Williams C; Bose M; Moore LJ; Wu ST; Maher J; Dreau D; Mukherjee AP
    Cells; 2019 Sep; 8(9):. PubMed ID: 31514488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MUC1 is responsible for the pro-metastatic potential of calycosin in pancreatic ductal adenocarcinoma.
    Chen W; Zhang Z; Yung KK; Ko JK
    Am J Cancer Res; 2022; 12(7):3242-3258. PubMed ID: 35968328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.